23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Autoantibodies frequency in children with visceral leishmaniosis

      abstract
      1 , 2 , , 1 , 1
      Pediatric Rheumatology Online Journal
      BioMed Central
      21st European Pediatric Rheumatology (PReS) Congress
      17-21 September 2014

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction The visceral leishmaniosis (VL), or Calazar, is a chronic severe systemic disease, potentially fatal to humans. Currently, VL is the prototype of a specific immune dysfunction resulting from parasitism of leishmania donovani in macrophages, producing a broad spectrum of clinical and immunological reversible only with specific treatment. Serum Analysis from infected adult patients demonstrated the presence of autoantibodies against cellular and humoral components, and circulating immune complexes. Objectives To identify the profile of autoantibodies in pediatric patients with VL and its correlation with clinical outcome. Methods Through a transversal study, was investigated the occurence of autoantibodies ( antinuclear antibodies (ANA), anti-DNA , anti-SM , anti-RNP , anti-SSb , anti-SSa, lupus anticoagulant, IgG and IgM anticardiolipin (aCL) antibodies ) in 34 patients (under 18 years) with diagnosis of VL, at the beginning and shortly after treatment, in the period October 2010 to March 2011. Results The incidence of autoantibodies present at the beginning in patients with VL was 64,7% (10 with ANA positive (29,4%), 7 with lupus anticoagulant antibodies positive (20,58%), 8 with IgM aCL antibodies positive (23,5%) and 5 with IgG aCL antibodie positive (14,7%) and 1 with Anti-RNP (2,9%). Sex, age, visceromegaly, nutritional status, treatment, use of corticosteroids, infections, hemophagocytic syndrome, febrile neutropenia, hemoglobin level and platelet count parameters were correlated with the presence of antibodies (table:1). It was found associated anaemia (p<0,05) with the antibody presence, but more studies are needed to evaluate the presence of hemolytic anemia associated. Infections: sepsis, pneumonia and urinary tract infection in 71,42% of total patients, but not correlated with antibodies. Autoimmunity was greatly reduced after treatment; the statistical significance remained after stratification in ANA. Conclusion Visceral leishmaniasis appears to correlate positively with the presence of ANA, lupus anticoagulant, IgG ang IgM aCL, in children, as in adults possibly by triggering a systemic humoral response of Th2. We found association statistically significant with lower hemoglobin level in these patients. Further studies are needed to evaluate the antibodies pattern in these infections. Disclosure of interest None declared.

          Related collections

          Author and article information

          Conference
          Pediatr Rheumatol Online J
          Pediatr Rheumatol Online J
          Pediatric Rheumatology Online Journal
          BioMed Central
          1546-0096
          2014
          17 September 2014
          : 12
          : Suppl 1
          : P101
          Affiliations
          [1 ]Pediatria, Hospital Dr Waldemar de Alcântara, Brazil
          [2 ]Pediatric rheumathology, Fortaleza University, Fortaleza, Brazil
          Article
          1546-0096-12-S1-P101
          10.1186/1546-0096-12-S1-P101
          4184170
          66bf5ad7-6277-4a4a-af66-5c40833b51d9
          Copyright © 2014 Paim-Marques et al; licensee BioMed Central Ltd.

          This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

          21st European Pediatric Rheumatology (PReS) Congress
          Belgrade, Serbia
          17-21 September 2014
          History
          Categories
          Poster Presentation

          Pediatrics
          Pediatrics

          Comments

          Comment on this article